Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine,valsartan, and hydrochlorothiazide for moderate to severe hypertension

Abstract

Objective:

To compare the antihypertensive efficacy and safety of once-daily triple therapy with amlodipine (Aml) 10?mg, valsartan (Val) 320?mg, and hydrochlorothiazide (HCTZ) 25?mg versus dual-therapy combinations of these components in patients with moderate to severe hypertension.